Blood Res.
2022 Apr;57(S1):S75-S78. 10.5045/br.2022.2022055.
Staging and response assessment of lymphoma: a brief review of the Lugano classification and the role of FDG-PET/CT
- Affiliations
-
- 1Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea
- KMID: 2529311
- DOI: http://doi.org/10.5045/br.2022.2022055
Abstract
- The accurate assessment of initial disease status and therapeutic responses is critical to the optimal management of patients with lymphoma. Currently, staging and treatment response evaluation for lymphoma has been standardized into the Lugano classification. Lugano classification incorporates positron emission tomography (PET) into the existing response criteria, and response assessment using FDG-PET/CT has been proven to predict the prognosis in various lymphoma subtypes effectively. We will briefly review the current staging and response evaluation system and explore the role of functional imaging in the field of lymphoma.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Application of Quantitative Indexes of FDG PET to Treatment Response Evaluation in Indolent Lymphoma
- Assessment of Tumor Response to Therapy in Lymphoma Using (18)F-FDG PET: Diagnostic Performance of (18)F-FDG PET and Interval Likelihood Ratio
- The Clinical Role of FDG PET in Malignant Lymphoma
- F-18 FDG PET/CT Findings of Subcutaneous Panniculitis - Like T- Cell Lymphoma : A Case Report
- Usefulness of F-18 FDG PET/CT in Staging of Peripheral T Cell Lymphoma
